Sort
15,842 grants matching “pancreatic cancer”
Regulation of Food Intake and Body Weight by GLP-1
$218,920Roger Reidelberger · Creighton University · R01 · FY2009 · DK
PDX-1 is a Therapeutic Target for Pancreatic Cancer
$218,813Francis Charles Brunicardi · University Of California Los Angeles · R01 · FY2012 · CA
Inference of tumor growth dynamics using genomic data
$218,790Subhajyoti De · Rbhs -Cancer Institute Of New Jersey · R21 · FY2020 · CA
Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma
$218,790John Eisenbrey · Thomas Jefferson University · R21 · FY2022 · CA
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies
$218,790Michael J Toth · University Of Vermont & St Agric College · R21 · FY2023 · CA
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
$218,790Juan Enrique Rozengurt · University Of California Los Angeles · R21 · FY2022 · CA
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach
$218,771Mack T Ruffin · University Of Michigan At Ann Arbor · P50 · FY2012 · CA
Drug-Induced Destabilization of Bcl-2 mRNA
$218,727Daniel James Fernandes · Medical University Of South Carolina · R01 · FY2007 · CA
Tumor-permeable nanoparticles for enhanced pancreatic cancer immunochemotherapy
$218,699Jingjing Sun · University Of Pittsburgh At Pittsburgh · R21 · FY2021 · CA
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
$218,588Peter Tattersall · Yale University · R21 · FY2020 · CA
PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis
$218,538Viji Shridhar · Mayo Clinic Rochester · R21 · FY2023 · CA
Manipulation of STAT3 Signaling for Muscle Preservation in Cancer Cachexia
$218,400Teresa A Zimmers · Indiana University Indianapolis · R01 · FY2013 · CA
Career Development Program
$218,327Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2012 · CA
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development
$218,284Robert M Straubinger · State University Of New York At Buffalo · R21 · FY2019 · CA
Mechanisms of RelA Activation in Cancer
$218,253Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Mechanisms of RelA Activation in Cancer
$218,253Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Cytosolic Ah Receptor: Mechanism of Action
$218,148Stephen H Safe · Texas A&M Agrilife Research · R21 · FY2015 · ES
Tissue Modeling and Drug Discovery Core
$218,134Hernan Alcides Flores-Rozas · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA
NF Center: From Animal Models to Therapeutics
$218,133David A Ingram · Ut Southwestern Medical Center · P50 · FY2009 · NS
TISSUE MODELING CORE
$218,130Paul Okunieff · University Of Florida · U54 · FY2018 · CA
PDX Core
$218,061Bingliang Fang · University Of Tx Md Anderson Can Ctr · U54 · FY2021 · CA
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
$218,060Scott Kopetz · University Of Tx Md Anderson Can Ctr · U54 · FY2021 · CA
ENHANCING EARLY DETECTION OF PANCREATIC CANCER USING GPT-EMBEDDED EHR MODELS: A NOVEL APPROACH FOR IMPROVED PREDICTIVE PERFORMANCE AND INTERPRETABILITY
$218,055The Trustees Of Columbia University In The City Of New York · · FY2025 · Defense Health Agency
ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION
$218,025Boston University Medical Campus · R01 · FY2002 · CA
ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION
$218,025Boston University Medical Campus · R01 · FY2003 · CA